Skip to main content
SpringerLink
Log in

Olfactory Neuroblastomas: Survival Rate and Prognostic Factor

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Olfactory neuroblastomas are known to be rare and clinically malignant tumors. The authors analyzed the clinical features, long-term treatment outcomes, and prognostic factors related to 21 cases of olfactory neuroblastomas, treated between January 1979 and October 2000, retrospectively reviewed with medical records and radiologic findings. The mean follow-up period was 28.7 months (range 4–178). The extent of tumor was classified according to the UCLA staging system. Statistical analysis for survival was done using the Kaplan–Meier method and the log-rank test. The mean age was 27 years (13–62), the peak incidence occurred in the second decade (8/21, 38%), and the male to female ratio was 13 : 8. According to the UCLA staging system, there were 3 cases of T1, 5 of T2, 6 of T3, and 7 of T4. The 5-year survival rate was 21.3% and the average survival time was 28.9 months. The group (n = 14) undergoing radical surgical resection as the primary modality, registered a higher survival rate than the radiation and chemotherapy group (n = 7), with 2-year survival rates being 76.2% vs. 14.3%, respectively (p = 0.0274). The early stage (T1, T2) groups exhibited a better survival rate than the advanced (T3, T4) groups with 5-year survival rates being 38.1% vs. 9.1%, respectively (p = 0.0336). The mean recurrence free time was 7.8 months (range 1–25). From these findings we could conclude that tumor detection in the early stage, radical surgical resection as the primary treatment modality, and regular follow-up with radiologic evaluation for recurrence or metastasis, represent important factors for an improved outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Broich G, Pagliari A, Ottaviani F: Esthesioneuroblastoma: a general review of the cases published since the discovery of the tumor in 1924. Anticancer Res 17: 2683–2706, 1996

    Google Scholar 

  2. Canty P: Olfactory neuroblastoma: long-term survival. J Laryngol Otol 93: 285–292, 1979

    Google Scholar 

  3. Eden BV, Debo RF, Larner JM, Kelly MD, Levine PA, Stewart FM, Cantrell RW, Constable WC: Esthesioneuroblastoma. Long-term outcome and patterns of failure-the University of Virginia experience. Cancer 73: 2556–2562, 1994

    Google Scholar 

  4. Eriksen JG, Bastholt L, Krogdahl AS, Hansen O, Joergensen KE: Esthesioneuroblastoma-what is the optimal treatment? Acta Oncol 39: 231–235, 2000

    Google Scholar 

  5. Jekunen AP, Kairemo KJ, Lehtonen HP, Kajanti MJ: Treatment of olfactory neuroblastoma. A report of 11 cases. Am J Clin Oncol 19: 375–378, 1996

    Google Scholar 

  6. Catalano PJ, Hecht CS, Biller HF, Lawson W, Post KD, Sachdev V, Sen C, Urken ML: Craniofacial resection. An analysis of 73 cases. Arch Otolaryngol Head Neck Surg 120: 1203–1208, 1994

    Google Scholar 

  7. Dulguerov P, Calcaterra T: Esthesioneuroblastoma: the UCLA experience 1970–1990. Laryngoscope 102: 843–849, 1992

    Google Scholar 

  8. McCutcheon IE, Blacklock JB, Weber RS, DeMonte F, Moser RP Byers M, Goepfert H: Anterior transcranial (craniofacial) resection of tumors of the paranasal sinuses: surgical technique and results. Neurosurgery 38: 471–479 discussion 479–480, 1996

    Google Scholar 

  9. Miyamoto RC, Gleich LL, Biddinger PW, Gluckana JL: Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis. Laryngoscope 110: 1262–1265, 2000

    Google Scholar 

  10. Morita A, Ebersold MJ, Olsen KD, Foote RL, Lewis JE, Quast LM: Esthesioneuroblastoma: prognosis and management. Neurosurgery 32: 706–715, 1993

    Google Scholar 

  11. Bumpous J, Janecka IP: Transorbital approaches to the cranial base. Clin Plast Surg 22: 461–481, 1995

    Google Scholar 

  12. Jackson IT, Somers P, Marsh WR: Esthesioneuroblastoma: treatment of skull-base recurrence. Plast Reconstr Surg 76: 195–201, 1985

    Google Scholar 

  13. Meneses MS, Thurel C, Mikol J, Ramina R, Maniglia JJ, Arruda WO, Cophignon J: Esthesioneuroblastoma with intracranial extension. Neurosurgery 27: 813–819 discussion 819–820, 1990

    Google Scholar 

  14. O'Connor TA, McLean P, Juillard GJ, Parker RG: Olfactory neuroblastoma. Cancer 63: 2426–2428, 1989

    Google Scholar 

  15. VanaclochaV, Saiz-Sapena N: Surgical treatment of anterior skull base tumors. Acta Neurochir (Wien) 139: 857–868, 1997

    Google Scholar 

  16. Shah JP, Feghali J: Esthesioneuroblastoma. Am J Surg 142: 456–458, 1981

    Google Scholar 

  17. Kadish S, Goodman M, Wang CC: Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer 37: 1571–1576, 1976

    Google Scholar 

  18. Biller HF, Lawson W, Sachdev VP, Son P: Esthesioneuroblastoma; surgical treatment without radiation. Laryngoscope 100: 1199–1201, 1190

    Google Scholar 

  19. Irish J, Dasgupta R, Freeman J, Gullane P, Gentili F, Brown D, Neligan P, O'Sullivan B: Outcome and analysis of the surgical management of esthesioneuroblastoma. J Otolaryngol 26: 1–7, 1997

    Google Scholar 

  20. Kasler M, Banhidy FG, Trizna Z: Experience with the modified pectoralis major myocutaneous flap. Arch Otolaryngol Head Neck Surg 118: 931–932, 1992

    Google Scholar 

  21. McCaffrey TV, Olsen Yohanan JM, Lewis JE, Ebersold MJ, Piepgras DG: Factors affecting survival of patients with tumors of the anterior skull base. Laryngoscope 104: 940–945, 1994

    Google Scholar 

  22. Shah JP, Kraus DH, Bilsky MH, Gutin PH, Harrison LH, Strong EW: Craniofacial resection for malignant tumors involving the anterior skull base. Arch Otolaryngol Head Neck Surg 123: 1312–1327, 1997

    Google Scholar 

  23. Solero CL, DiMeco F, Sampath P, Mattavelli F, Pizzi N, Salvatori P, Cantu G: Combined anterior craniofacial resection for tumors involving the cribriform plate: early postoperative complications and technical resection for tumors 226 involving the cribriform plate: early postoperative complications and technical considerations. Neurosurgery 47: 1296–1305, 2000

    Google Scholar 

  24. Raveh J, Turk JB, Ladrach K, Seiler R, Godoy N, Chen J, Paladino J, Virag M, Leibinger K: Extended anterior subcranial approach for skull base tumors: long-term results. J Neurosurg 82: 1002–1010, 1995

    Google Scholar 

  25. Chapman P, Carter RL, Clifford P: The diagnosis and surgical management of olfactory neuroblastoma: the role of craniofacial resection. J Laryngol Otol </del>95: 785–799, 1981

    Google Scholar 

  26. Slevin NJ, Irwin CJ, Banerjee SS, Gupta NK, Farrington WT: Olfactory neural tumors-the role of external beam radiotherapy. J Laryngol Otol 110: 1012–1016, 1996

    Google Scholar 

  27. Polin RS, Sheehan JP, Chenelle AG, Munoz E, Larner J, Phillips CD, Cantrell RW, Laws ER Jr, Newman SA, Levine PA, Jane JA: The role of preoperative adjuvant treatment in the management of esthesioneuroblastoma: the University of Virginia experience. Neurosurgery 42: 1029–1037, 1998

    Google Scholar 

  28. Koka VN, Julieron M, Bourhis J, Janot F, Le Ridant AM, Marandas P, Luboinski B, Schwaab G: Aesthesioneuroblastoma. J Laryngol Otol 112: 628–633, 1998

    Google Scholar 

  29. Bilsky MH, Strong EW, Harrison LB, Gutin PH, Shah JP: Extended anterior craniofacial resection for intracranial extension of malignant tumors. Am J Surg 174: 565–568, 1997

    Google Scholar 

  30. Levine PA, Debo RF, Meredith SD, Jane JA, Constable WC, Cantrell RW: Craniofacial resection at the University of Virginia (1976–1992): survival analysis. Head Neck 16: 574–577, 1994

    Google Scholar 

  31. Levine PA, Gallagher R, Cantrell RW: Esthesioneuroblastoma: reflections of a 21-year experience. Laryngoscope 109: 1539–1543, 1999

    Google Scholar 

  32. Lund VJ, Howard DJ, Wei WI, Cheesman AD: Craniofacial resection for tumors of the nasal cavity and paranasal sinuses-a 17-year experience. Head Neck 20: 97–105, 1998

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Ewha Womans University College of Medicine, Seoul, Korea

    Sung-Kyun Hwang

  2. Neuroscience Research Institute, Seoul National University Medical Research Center, Seoul, Korea

    Sun-Ha Paek & Dong Gyu Kim

  3. Departments of Pathology, Seoul National University College of Medicine, Seoul, Korea

    Yoon-Kyung Jeon & Je G. Chi

  4. Clinical Research Institute, Seoul National University Hospital, Seoul, Korea

    Hee-Won Jung

Authors
  1. Sung-Kyun Hwang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sun-Ha Paek
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dong Gyu Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yoon-Kyung Jeon
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Je G. Chi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hee-Won Jung
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hwang, SK., Paek, SH., Gyu Kim, D. et al. Olfactory Neuroblastomas: Survival Rate and Prognostic Factor. J Neurooncol 59, 217–226 (2002). https://doi.org/10.1023/A:1019937503469

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1019937503469

Search

Navigation